F. Yi

发表

Topotecan plus Platinum-Based Chemotherapy versus Etoposide plus Platinum-Based Chemotherapy for Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Yiping Wei, Wenxiong Zhang, Jinhua Peng, 2021, Chemotherapy.

The value of serum cystatin C in early evaluation of renal insufficiency in patients undergoing chemotherapy: a systematic review and meta-analysis

Xiude Fan, Yiping Wei, Wenxiong Zhang, 2019, Cancer Chemotherapy and Pharmacology.

The benefits and risks of CTLA4 inhibitor plus PD1/PDL1 inhibitor in stage IIIB/IV non‐small cell lung cancer: A systematic analysis and meta‐analysis based on randomized controlled trials

Yiping Wei, Wenxiong Zhang, Qiangyun Liu, 2021, Journal of clinical pharmacy and therapeutics.

Necitumumab plus platinum-based chemotherapy versus chemotherapy alone as first-line treatment for stage IV non-small cell lung cancer: a meta-analysis based on randomized controlled trials.

Meng Li, Yiping Wei, Wenxiong Zhang, 2020, Annals of Palliative Medicine.

Early versus late closure of temporary ileostomy after rectal cancer surgery: a meta-analysis

Xinling Chen, Yiping Wei, Wenxiong Zhang, 2020, Surgery Today.

Comparison of Platinum/S-1 and Platinum/5-Fluorouracil as First-Line Chemotherapy for Advanced Gastric or Gastroesophageal Junction Cancer: A Meta-Analysis Based on Randomized Controlled Trials

Hao Ding, Xinling Chen, Yiping Wei, 2020, Chemotherapy.

Efficacy and Safety of Regorafenib Combined with Toripalimab in the Third-Line and beyond Treatment of Advanced Colorectal Cancer

Long Feng, Q. Tao, F. Yi, 2021, Journal of oncology.

The efficacy and toxicity of maintenance therapy with bevacizumab plus pemetrexed versus bevacizumab/pemetrexed alone for stage IIIB/IV nonsquamous non‐small cell lung cancer: A meta‐analysis of randomized controlled trials

Nachuan Luo, Yiping Wei, Wenxiong Zhang, 2021, Journal of clinical pharmacy and therapeutics.

A 2/1 Sunitinib Dosing Schedule Provides Superior Antitumor Effectiveness and Less Toxicity Than a 4/2 Schedule for Metastatic Renal Cell Carcinoma: A Systematic Review and Meta-Analysis

Zhengdong Hong, Yiping Wei, Wenxiong Zhang, 2019, Frontiers in Oncology.

Preoperative Serum Platelet-Lymphocyte Ratio as a Prognostic Factor in Cholangiocarcinoma Patients after Radical Resection: A Retrospective Analysis of 119 Patients

F. Yi, Ying Wu, Long Feng, 2019, Gastroenterology research and practice.

Talc pleurodesis versus indwelling pleural catheter among patients with malignant pleural effusion: a meta-analysis of randomized controlled trials

Xinling Chen, Yiping Wei, Wenxiong Zhang, 2020, World Journal of Surgical Oncology.

Use of dexamethasone and a 5-HT3 receptor antagonist with or without aprepitant to prevent chemotherapy-induced nausea and vomiting among patients with lung cancer who are treated with platinum-based chemotherapy: a systematic review and meta-analysis of randomized controlled trials.

Yiping Wei, Wenxiong Zhang, Mengyu He, 2021, Annals of palliative medicine.

Comparison of Different First-Line Systemic Therapies in Advanced Biliary Tract Cancer Based on Updated Random Controlled Trials: A Systematic Review and Network Meta-Analysis

Long Feng, F. Yi, Ying Wang, 2022, BioMed research international.

Efficacy of bevacizumab combined with erlotinib for advanced hepatocellular carcinoma: a single-arm meta-analysis based on prospective studies

Yiping Wei, Jianjun Xu, Wenxiong Zhang, 2019, BMC Cancer.

Docetaxel, cisplatin, and 5-fluorouracil compared with epirubicin, cisplatin, and 5-fluorouracil regimen for advanced gastric cancer: A systematic review and meta-analysis

Wenxiong Zhang, F. Yi, Hongliang Luo, 2019, World journal of clinical cases.

Evaluation of fecal protein S100A12 in patients with inflammatory bowel disease

Jianbing Wu, F. Yi, Long Feng, 2017 .

Efficacy and safety of different options for liver regeneration of future liver remnant in patients with liver malignancies: a systematic review and network meta-analysis

Long Feng, Wei Zhang, F. Yi, 2022, World journal of surgical oncology.

Comparative Efficacy, Safety, and Costs of Sorafenib vs. Sunitinib as First-Line Therapy for Metastatic Renal Cell Carcinoma: A Systematic Review and Meta-Analysis

Zhengdong Hong, Yiping Wei, Wenxiong Zhang, 2019, Front. Oncol..

The benefits and risks of pembrolizumab in combination with chemotherapy as first-line therapy in small-cell lung cancer: a single-arm meta-analysis of noncomparative clinical studies and randomized control trials

Yiping Wei, Wenxiong Zhang, Qiangyun Liu, 2021, World Journal of Surgical Oncology.

Inhibition of histone deacetylase 11 promotes human liver cancer cell apoptosis.

Jianbing Wu, Dan Gong, F. Yi, 2019, American journal of translational research.

Erlotinib plus tivantinib versus erlotinib alone in patients with previously treated stage IIIb/IV non–small-cell lung cancer

Xinling Chen, Yiping Wei, Wenxiong Zhang, 2020, Medicine.

Stereotactic Body Radiotherapy Combined with Transcatheter Arterial Chemoembolization versus Stereotactic Body Radiotherapy Alone as the First-Line Treatment for Unresectable Hepatocellular Carcinoma: A Meta-Analysis and Systematic Review

Yiping Wei, Wenxiong Zhang, J. Lei, 2020, Chemotherapy.

Expression of DOG1 in peripheral blood cells of patients with gastrointestinal stromal tumor.

F. Yi, Long Feng, Jinfeng Luo, 2021, Arab journal of gastroenterology : the official publication of the Pan-Arab Association of Gastroenterology.

Nivolumab provides improved effectiveness and safety compared with docetaxel as a second‐line treatment for advanced non‐small cell lung cancer: A systematic review and meta‐analysis

Yiping Wei, Jianjun Xu, Wenxiong Zhang, 2019, Cancer medicine.

A meta-analysis comparing stereotactic body radiotherapy vs conventional radiotherapy in inoperable stage I non-small cell lung cancer

Yiping Wei, Jianjun Xu, Wenxiong Zhang, 2020, Medicine.

Isolation and phenotypic characterization of cancer stem-like side population cells in colon cancer.

Jianbing Wu, F. Yi, Long Feng, 2015, Molecular medicine reports.

A Meta-Analysis of the Efficacy and Toxicity of Twice-Daily vs. Once-Daily Concurrent Chemoradiotherapy for Limited-Stage Small Cell Lung Cancer Based on Randomized Controlled Trials

Xinling Chen, Yiping Wei, Wenxiong Zhang, 2020, Frontiers in Oncology.

Comparison of transcatheter arterial chemoembolization combined with radiofrequency ablation or microwave ablation for the treatment of unresectable hepatocellular carcinoma: a systemic review and meta-analysis

Yiping Wei, Wenxiong Zhang, J. Lei, 2020, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

Efficacy of bevacizumab combined with erlotinib for advanced hepatocellular carcinoma: a single-arm meta-analysis based on prospective studies

Yiping Wei, Jianjun Xu, Wenxiong Zhang, 2019, BMC cancer.

PARP inhibitor plus chemotherapy versus chemotherapy alone in patients with triple-negative breast cancer: a systematic review and meta-analysis based on randomized controlled trials

Yiping Wei, Wenxiong Zhang, Z. Fang, 2023, Cancer Chemotherapy and Pharmacology.

Effects of siRNA targeting BMPR-II on the biological activities of human liver cancer cells and its mechanism

Jianbing Wu, P. Zeng, F. Yi, 2014, Cancer Cell International.

Anastrozole plus fulvestrant vs. anastrozole alone for hormone receptor-positive advanced breast cancer: a meta-analysis of randomized controlled trials

Meng Li, Yiping Wei, Wenxiong Zhang, 2020, Breast Cancer Research and Treatment.

Three-dimensional vs 2-dimensional laparoscopic gastrectomy for gastric cancer

Wenxiong Zhang, J. Lei, Jiani Zhao, 2019, Medicine.

Glutamine metabolic reprogramming in hepatocellular carcinoma

F. Yi, Y. Ye, Hua Wang, 2023, Frontiers in molecular biosciences.

Network meta-analysis of adjuvant treatments for patients with hepatocellular carcinoma after curative resection

F. Yi, Haoqian Xu, Yanyan Ye, 2023, BMC Gastroenterology.

Efficacy and safety of hepatic arterial infusion chemotherapy combined with lenvatinib and PD-1 inhibitors for advanced hepatocellular carcinoma with macrovascular invasion

F. Yi, Yufeng Zhang, Haoqian Xu, 2024, World journal of surgical oncology.

Nivolumab provides improved effectiveness and safety compared with docetaxel as a second‐line treatment for advanced non‐small cell lung cancer: A systematic review and meta‐analysis

Yiping Wei, Jianjun Xu, Wenxiong Zhang, 2019, Cancer medicine.

A systematic review and meta-analysis

Jiani Zhao, F. Yi, Lianli Zeng, 2019 .

Effects of siRNA targeting BMPR-II on the biological activities of human liver cancer cells and its mechanism

Jianbing Wu, P. Zeng, F. Yi, 2014, Cancer Cell International.

Biomarkers of Inflammatory Bowel Disease

F. Yi, Wu Jianbing, Yi Fengming, 2014, Disease markers.